Skip to content

PTC Therapeutics PTCT Earnings yield

Earnings yield at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
5%+2.6pp
ALN
Alnylam PharmaceuticalsALNY
1.1%+0.8pp
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-5.7%-2.6pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-5.1%-1.7pp
Biogen logo
BiogenBIIB
5.3%-2.1pp
Scholar Rock logo
Scholar RockSRRK
-7.2%-1.0pp

Other financials

Income statement

See full
Revenue$272.6M-76.8%
Operating income$45.0M-95.4%
Net income-$2.8M-100%
EPS (diluted)-$0.03-100%

Balance sheet

See full
Cash & equivalents$834.0M-43.7%
Total debt$395.1M+0.1%
Total equity-$180.5M+2.9%
Total assets$2.9B+8.0%

Cash flow

See full
Operating cash flow-$59.0M-107%
CapEx$1.2M-30.6%
Free cash flow-$60.2M-107%

Valuation

See full
Market cap$6.55B+40.3%
Enterprise value$6.11B+77.3%
P/E
P/S7.9×+5.3×

Profitability

See full
Gross margin96%
Operating margin1.6%-38.7pp
Net margin42.3%+27.4pp
FCF margin39.1%+32.8pp

Returns & leverage

See full
Return on equity-216.7%
Debt / equity372.3×
Current ratio2.4×-1.5×

Where this comes from

Calculated from PTC Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: PTC Therapeutics’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about PTC Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTC Therapeutics's earnings yield?
PTC Therapeutics (PTCT) reported earnings yield of 15.4% in Q3 2025.
How has PTC Therapeutics's earnings yield changed year-over-year?
PTC Therapeutics's earnings yield increased by 196.8% year-over-year, from -15.9% to 15.4%.
What is the long-term trend for PTC Therapeutics's earnings yield?
Over 4 years (2020 to 2024), PTC Therapeutics's earnings yield has grown at a 0.7% compound annual growth rate (CAGR), from -10.2% to -10.4%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.